nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.303	1	CbGaD
Zolmitriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.11	0.285	CbGbCtD
Zolmitriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.106	0.273	CbGbCtD
Zolmitriptan—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0663	0.171	CbGbCtD
Zolmitriptan—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0344	0.0888	CbGbCtD
Zolmitriptan—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0271	0.0699	CbGbCtD
Zolmitriptan—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.0256	0.0661	CbGbCtD
Zolmitriptan—CYP1A2—Losartan—type 2 diabetes mellitus	0.0174	0.0451	CbGbCtD
Zolmitriptan—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00208	0.378	CrCbGaD
Zolmitriptan—Melatonin—MTNR1B—type 2 diabetes mellitus	0.00109	0.198	CrCbGaD
Zolmitriptan—Melatonin—CALM1—type 2 diabetes mellitus	0.000671	0.122	CrCbGaD
Zolmitriptan—HTR1B—artery—type 2 diabetes mellitus	0.000562	0.155	CbGeAlD
Zolmitriptan—HTR1D—artery—type 2 diabetes mellitus	0.000544	0.15	CbGeAlD
Zolmitriptan—Rizatriptan—CYP1A2—type 2 diabetes mellitus	0.00045	0.0816	CrCbGaD
Zolmitriptan—MAOA—nerve—type 2 diabetes mellitus	0.000411	0.113	CbGeAlD
Zolmitriptan—Almotriptan—CYP2E1—type 2 diabetes mellitus	0.000328	0.0595	CrCbGaD
Zolmitriptan—Almotriptan—CYP1A2—type 2 diabetes mellitus	0.000312	0.0566	CrCbGaD
Zolmitriptan—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000211	0.0382	CrCbGaD
Zolmitriptan—Almotriptan—CYP3A4—type 2 diabetes mellitus	0.000207	0.0375	CrCbGaD
Zolmitriptan—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000199	0.0549	CbGeAlD
Zolmitriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000195	0.0539	CbGeAlD
Zolmitriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000189	0.0521	CbGeAlD
Zolmitriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000185	0.051	CbGeAlD
Zolmitriptan—MAOA—retina—type 2 diabetes mellitus	0.00017	0.0469	CbGeAlD
Zolmitriptan—Eletriptan—CYP3A4—type 2 diabetes mellitus	0.000161	0.0292	CrCbGaD
Zolmitriptan—MAOA—nephron tubule—type 2 diabetes mellitus	0.00016	0.0442	CbGeAlD
Zolmitriptan—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000158	0.0435	CbGeAlD
Zolmitriptan—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000144	0.0397	CbGeAlD
Zolmitriptan—MAOA—kidney—type 2 diabetes mellitus	0.000141	0.0389	CbGeAlD
Zolmitriptan—MAOA—pancreas—type 2 diabetes mellitus	0.00014	0.0386	CbGeAlD
Zolmitriptan—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000137	0.0378	CbGeAlD
Zolmitriptan—MAOA—adipose tissue—type 2 diabetes mellitus	0.000127	0.035	CbGeAlD
Zolmitriptan—Angioedema—Losartan—type 2 diabetes mellitus	9.82e-05	0.00046	CcSEcCtD
Zolmitriptan—Infection—Metformin—type 2 diabetes mellitus	9.82e-05	0.000459	CcSEcCtD
Zolmitriptan—Insomnia—Valsartan—type 2 diabetes mellitus	9.81e-05	0.000459	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.77e-05	0.000457	CcSEcCtD
Zolmitriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.74e-05	0.000456	CcSEcCtD
Zolmitriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.73e-05	0.000456	CcSEcCtD
Zolmitriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000455	CcSEcCtD
Zolmitriptan—Chest pain—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000455	CcSEcCtD
Zolmitriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	9.73e-05	0.000455	CcSEcCtD
Zolmitriptan—Shock—Metformin—type 2 diabetes mellitus	9.72e-05	0.000455	CcSEcCtD
Zolmitriptan—Insomnia—Orlistat—type 2 diabetes mellitus	9.7e-05	0.000454	CcSEcCtD
Zolmitriptan—Malaise—Losartan—type 2 diabetes mellitus	9.7e-05	0.000454	CcSEcCtD
Zolmitriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	9.69e-05	0.000454	CcSEcCtD
Zolmitriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.69e-05	0.000454	CcSEcCtD
Zolmitriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.69e-05	0.000454	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Metformin—type 2 diabetes mellitus	9.67e-05	0.000453	CcSEcCtD
Zolmitriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	9.67e-05	0.000453	CcSEcCtD
Zolmitriptan—Vertigo—Losartan—type 2 diabetes mellitus	9.66e-05	0.000452	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	9.66e-05	0.000452	CcSEcCtD
Zolmitriptan—Somnolence—Valsartan—type 2 diabetes mellitus	9.65e-05	0.000451	CcSEcCtD
Zolmitriptan—Syncope—Losartan—type 2 diabetes mellitus	9.64e-05	0.000451	CcSEcCtD
Zolmitriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	9.63e-05	0.000451	CcSEcCtD
Zolmitriptan—Leukopenia—Losartan—type 2 diabetes mellitus	9.62e-05	0.00045	CcSEcCtD
Zolmitriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	9.61e-05	0.00045	CcSEcCtD
Zolmitriptan—Skin disorder—Metformin—type 2 diabetes mellitus	9.6e-05	0.000449	CcSEcCtD
Zolmitriptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000448	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	9.55e-05	0.000447	CcSEcCtD
Zolmitriptan—Dyspepsia—Valsartan—type 2 diabetes mellitus	9.55e-05	0.000447	CcSEcCtD
Zolmitriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	9.51e-05	0.000445	CcSEcCtD
Zolmitriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	9.51e-05	0.000445	CcSEcCtD
Zolmitriptan—Palpitations—Losartan—type 2 diabetes mellitus	9.5e-05	0.000445	CcSEcCtD
Zolmitriptan—Nausea—Glimepiride—type 2 diabetes mellitus	9.47e-05	0.000443	CcSEcCtD
Zolmitriptan—Arrhythmia—Ramipril—type 2 diabetes mellitus	9.46e-05	0.000443	CcSEcCtD
Zolmitriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	9.45e-05	0.000442	CcSEcCtD
Zolmitriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	9.44e-05	0.000442	CcSEcCtD
Zolmitriptan—Dyspepsia—Orlistat—type 2 diabetes mellitus	9.44e-05	0.000442	CcSEcCtD
Zolmitriptan—Asthenia—Glyburide—type 2 diabetes mellitus	9.44e-05	0.000442	CcSEcCtD
Zolmitriptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	9.43e-05	0.000441	CcSEcCtD
Zolmitriptan—Anorexia—Metformin—type 2 diabetes mellitus	9.42e-05	0.000441	CcSEcCtD
Zolmitriptan—Cough—Losartan—type 2 diabetes mellitus	9.38e-05	0.000439	CcSEcCtD
Zolmitriptan—Urticaria—Gliclazide—type 2 diabetes mellitus	9.38e-05	0.000439	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	9.37e-05	0.000438	CcSEcCtD
Zolmitriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.000437	CcSEcCtD
Zolmitriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	9.34e-05	0.000437	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000436	CcSEcCtD
Zolmitriptan—Oedema—Irbesartan—type 2 diabetes mellitus	9.32e-05	0.000436	CcSEcCtD
Zolmitriptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	9.32e-05	0.000436	CcSEcCtD
Zolmitriptan—Pruritus—Glyburide—type 2 diabetes mellitus	9.3e-05	0.000436	CcSEcCtD
Zolmitriptan—Constipation—Valsartan—type 2 diabetes mellitus	9.28e-05	0.000434	CcSEcCtD
Zolmitriptan—Infection—Irbesartan—type 2 diabetes mellitus	9.26e-05	0.000434	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	9.26e-05	0.000433	CcSEcCtD
Zolmitriptan—Erythema—Ramipril—type 2 diabetes mellitus	9.22e-05	0.000432	CcSEcCtD
Zolmitriptan—Shock—Irbesartan—type 2 diabetes mellitus	9.17e-05	0.000429	CcSEcCtD
Zolmitriptan—Pain—Orlistat—type 2 diabetes mellitus	9.17e-05	0.000429	CcSEcCtD
Zolmitriptan—Arthralgia—Losartan—type 2 diabetes mellitus	9.15e-05	0.000428	CcSEcCtD
Zolmitriptan—Myalgia—Losartan—type 2 diabetes mellitus	9.15e-05	0.000428	CcSEcCtD
Zolmitriptan—Chest pain—Losartan—type 2 diabetes mellitus	9.15e-05	0.000428	CcSEcCtD
Zolmitriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	9.15e-05	0.000428	CcSEcCtD
Zolmitriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	9.14e-05	0.000428	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	9.13e-05	0.000427	CcSEcCtD
Zolmitriptan—Anxiety—Losartan—type 2 diabetes mellitus	9.12e-05	0.000427	CcSEcCtD
Zolmitriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	9.1e-05	0.000426	CcSEcCtD
Zolmitriptan—Rash—Bromocriptine—type 2 diabetes mellitus	9.07e-05	0.000425	CcSEcCtD
Zolmitriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	9.06e-05	0.000424	CcSEcCtD
Zolmitriptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	9.06e-05	0.000424	CcSEcCtD
Zolmitriptan—Tension—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000423	CcSEcCtD
Zolmitriptan—Discomfort—Losartan—type 2 diabetes mellitus	9.04e-05	0.000423	CcSEcCtD
Zolmitriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000423	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	9.01e-05	0.000422	CcSEcCtD
Zolmitriptan—Headache—Bromocriptine—type 2 diabetes mellitus	9.01e-05	0.000422	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	9e-05	0.000421	CcSEcCtD
Zolmitriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	9e-05	0.000421	CcSEcCtD
Zolmitriptan—Nervousness—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000419	CcSEcCtD
Zolmitriptan—Dry mouth—Losartan—type 2 diabetes mellitus	8.95e-05	0.000419	CcSEcCtD
Zolmitriptan—MAOA—liver—type 2 diabetes mellitus	8.9e-05	0.0246	CbGeAlD
Zolmitriptan—Anorexia—Irbesartan—type 2 diabetes mellitus	8.89e-05	0.000416	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.87e-05	0.000415	CcSEcCtD
Zolmitriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	8.87e-05	0.000415	CcSEcCtD
Zolmitriptan—Muscle spasms—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000415	CcSEcCtD
Zolmitriptan—Confusional state—Losartan—type 2 diabetes mellitus	8.85e-05	0.000414	CcSEcCtD
Zolmitriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.83e-05	0.000414	CcSEcCtD
Zolmitriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	8.81e-05	0.000412	CcSEcCtD
Zolmitriptan—Somnolence—Metformin—type 2 diabetes mellitus	8.78e-05	0.000411	CcSEcCtD
Zolmitriptan—Oedema—Losartan—type 2 diabetes mellitus	8.78e-05	0.000411	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.78e-05	0.000411	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.77e-05	0.00041	CcSEcCtD
Zolmitriptan—Infection—Losartan—type 2 diabetes mellitus	8.72e-05	0.000408	CcSEcCtD
Zolmitriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.7e-05	0.000407	CcSEcCtD
Zolmitriptan—Dyspepsia—Metformin—type 2 diabetes mellitus	8.7e-05	0.000407	CcSEcCtD
Zolmitriptan—Tremor—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000404	CcSEcCtD
Zolmitriptan—Shock—Losartan—type 2 diabetes mellitus	8.63e-05	0.000404	CcSEcCtD
Zolmitriptan—Urticaria—Valsartan—type 2 diabetes mellitus	8.62e-05	0.000403	CcSEcCtD
Zolmitriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.61e-05	0.000403	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Losartan—type 2 diabetes mellitus	8.59e-05	0.000402	CcSEcCtD
Zolmitriptan—Decreased appetite—Metformin—type 2 diabetes mellitus	8.59e-05	0.000402	CcSEcCtD
Zolmitriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	8.58e-05	0.000401	CcSEcCtD
Zolmitriptan—Tachycardia—Losartan—type 2 diabetes mellitus	8.56e-05	0.000401	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	8.55e-05	0.0004	CcSEcCtD
Zolmitriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	8.55e-05	0.0004	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	8.53e-05	0.000399	CcSEcCtD
Zolmitriptan—Urticaria—Orlistat—type 2 diabetes mellitus	8.52e-05	0.000399	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.000398	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	8.48e-05	0.000397	CcSEcCtD
Zolmitriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	8.48e-05	0.000397	CcSEcCtD
Zolmitriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	8.48e-05	0.000397	CcSEcCtD
Zolmitriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	8.47e-05	0.000397	CcSEcCtD
Zolmitriptan—Agitation—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000397	CcSEcCtD
Zolmitriptan—Constipation—Metformin—type 2 diabetes mellitus	8.45e-05	0.000395	CcSEcCtD
Zolmitriptan—Angioedema—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000394	CcSEcCtD
Zolmitriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	8.37e-05	0.000392	CcSEcCtD
Zolmitriptan—Anorexia—Losartan—type 2 diabetes mellitus	8.36e-05	0.000392	CcSEcCtD
Zolmitriptan—Vomiting—Glyburide—type 2 diabetes mellitus	8.36e-05	0.000391	CcSEcCtD
Zolmitriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	8.36e-05	0.000391	CcSEcCtD
Zolmitriptan—Malaise—Ramipril—type 2 diabetes mellitus	8.31e-05	0.000389	CcSEcCtD
Zolmitriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	8.31e-05	0.000389	CcSEcCtD
Zolmitriptan—Rash—Glyburide—type 2 diabetes mellitus	8.29e-05	0.000388	CcSEcCtD
Zolmitriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	8.29e-05	0.000388	CcSEcCtD
Zolmitriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	8.28e-05	0.000388	CcSEcCtD
Zolmitriptan—Vertigo—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000388	CcSEcCtD
Zolmitriptan—Syncope—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000387	CcSEcCtD
Zolmitriptan—Leukopenia—Ramipril—type 2 diabetes mellitus	8.25e-05	0.000386	CcSEcCtD
Zolmitriptan—Headache—Glyburide—type 2 diabetes mellitus	8.24e-05	0.000386	CcSEcCtD
Zolmitriptan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000384	CcSEcCtD
Zolmitriptan—Palpitations—Ramipril—type 2 diabetes mellitus	8.15e-05	0.000381	CcSEcCtD
Zolmitriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	8.14e-05	0.000381	CcSEcCtD
Zolmitriptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	8.11e-05	0.000379	CcSEcCtD
Zolmitriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000379	CcSEcCtD
Zolmitriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.000378	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	8.08e-05	0.000378	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	8.05e-05	0.000377	CcSEcCtD
Zolmitriptan—Cough—Ramipril—type 2 diabetes mellitus	8.05e-05	0.000377	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.99e-05	0.000374	CcSEcCtD
Zolmitriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000374	CcSEcCtD
Zolmitriptan—Convulsion—Ramipril—type 2 diabetes mellitus	7.99e-05	0.000374	CcSEcCtD
Zolmitriptan—Constipation—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000373	CcSEcCtD
Zolmitriptan—Pain—Irbesartan—type 2 diabetes mellitus	7.97e-05	0.000373	CcSEcCtD
Zolmitriptan—Insomnia—Losartan—type 2 diabetes mellitus	7.94e-05	0.000371	CcSEcCtD
Zolmitriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.9e-05	0.00037	CcSEcCtD
Zolmitriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	7.88e-05	0.000369	CcSEcCtD
Zolmitriptan—Urticaria—Metformin—type 2 diabetes mellitus	7.85e-05	0.000367	CcSEcCtD
Zolmitriptan—Chest pain—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000367	CcSEcCtD
Zolmitriptan—Myalgia—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000367	CcSEcCtD
Zolmitriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	7.85e-05	0.000367	CcSEcCtD
Zolmitriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	7.82e-05	0.000366	CcSEcCtD
Zolmitriptan—Anxiety—Ramipril—type 2 diabetes mellitus	7.82e-05	0.000366	CcSEcCtD
Zolmitriptan—Nausea—Glyburide—type 2 diabetes mellitus	7.81e-05	0.000366	CcSEcCtD
Zolmitriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	7.81e-05	0.000366	CcSEcCtD
Zolmitriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	7.81e-05	0.000366	CcSEcCtD
Zolmitriptan—Somnolence—Losartan—type 2 diabetes mellitus	7.8e-05	0.000365	CcSEcCtD
Zolmitriptan—Asthenia—Valsartan—type 2 diabetes mellitus	7.78e-05	0.000364	CcSEcCtD
Zolmitriptan—Discomfort—Ramipril—type 2 diabetes mellitus	7.76e-05	0.000363	CcSEcCtD
Zolmitriptan—Dyspepsia—Losartan—type 2 diabetes mellitus	7.72e-05	0.000362	CcSEcCtD
Zolmitriptan—Asthenia—Orlistat—type 2 diabetes mellitus	7.69e-05	0.00036	CcSEcCtD
Zolmitriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.68e-05	0.00036	CcSEcCtD
Zolmitriptan—Pruritus—Valsartan—type 2 diabetes mellitus	7.68e-05	0.000359	CcSEcCtD
Zolmitriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	7.68e-05	0.000359	CcSEcCtD
Zolmitriptan—Decreased appetite—Losartan—type 2 diabetes mellitus	7.63e-05	0.000357	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000357	CcSEcCtD
Zolmitriptan—Confusional state—Ramipril—type 2 diabetes mellitus	7.59e-05	0.000355	CcSEcCtD
Zolmitriptan—Pruritus—Orlistat—type 2 diabetes mellitus	7.59e-05	0.000355	CcSEcCtD
Zolmitriptan—Oedema—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000352	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7.52e-05	0.000352	CcSEcCtD
Zolmitriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	7.51e-05	0.000351	CcSEcCtD
Zolmitriptan—Pain—Losartan—type 2 diabetes mellitus	7.5e-05	0.000351	CcSEcCtD
Zolmitriptan—Constipation—Losartan—type 2 diabetes mellitus	7.5e-05	0.000351	CcSEcCtD
Zolmitriptan—Rash—Gliclazide—type 2 diabetes mellitus	7.45e-05	0.000349	CcSEcCtD
Zolmitriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	7.44e-05	0.000348	CcSEcCtD
Zolmitriptan—CYP1A2—liver—type 2 diabetes mellitus	7.43e-05	0.0205	CbGeAlD
Zolmitriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000347	CcSEcCtD
Zolmitriptan—Urticaria—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000347	CcSEcCtD
Zolmitriptan—Shock—Ramipril—type 2 diabetes mellitus	7.4e-05	0.000347	CcSEcCtD
Zolmitriptan—Headache—Gliclazide—type 2 diabetes mellitus	7.4e-05	0.000346	CcSEcCtD
Zolmitriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	7.38e-05	0.000345	CcSEcCtD
Zolmitriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000345	CcSEcCtD
Zolmitriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	7.37e-05	0.000345	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	7.37e-05	0.000345	CcSEcCtD
Zolmitriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	7.34e-05	0.000344	CcSEcCtD
Zolmitriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000343	CcSEcCtD
Zolmitriptan—Skin disorder—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000342	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	7.27e-05	0.00034	CcSEcCtD
Zolmitriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	7.23e-05	0.000338	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	7.18e-05	0.000336	CcSEcCtD
Zolmitriptan—Dizziness—Valsartan—type 2 diabetes mellitus	7.17e-05	0.000336	CcSEcCtD
Zolmitriptan—Anorexia—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000336	CcSEcCtD
Zolmitriptan—Dizziness—Orlistat—type 2 diabetes mellitus	7.09e-05	0.000332	CcSEcCtD
Zolmitriptan—Asthenia—Metformin—type 2 diabetes mellitus	7.09e-05	0.000332	CcSEcCtD
Zolmitriptan—Nausea—Gliclazide—type 2 diabetes mellitus	7.01e-05	0.000328	CcSEcCtD
Zolmitriptan—Pruritus—Metformin—type 2 diabetes mellitus	6.99e-05	0.000327	CcSEcCtD
Zolmitriptan—Urticaria—Losartan—type 2 diabetes mellitus	6.97e-05	0.000326	CcSEcCtD
Zolmitriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	6.94e-05	0.000325	CcSEcCtD
Zolmitriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	6.94e-05	0.000325	CcSEcCtD
Zolmitriptan—Vomiting—Valsartan—type 2 diabetes mellitus	6.9e-05	0.000323	CcSEcCtD
Zolmitriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000322	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.86e-05	0.000321	CcSEcCtD
Zolmitriptan—Rash—Valsartan—type 2 diabetes mellitus	6.84e-05	0.00032	CcSEcCtD
Zolmitriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	6.83e-05	0.00032	CcSEcCtD
Zolmitriptan—Vomiting—Orlistat—type 2 diabetes mellitus	6.82e-05	0.000319	CcSEcCtD
Zolmitriptan—Insomnia—Ramipril—type 2 diabetes mellitus	6.81e-05	0.000319	CcSEcCtD
Zolmitriptan—Headache—Valsartan—type 2 diabetes mellitus	6.8e-05	0.000318	CcSEcCtD
Zolmitriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	6.76e-05	0.000316	CcSEcCtD
Zolmitriptan—Rash—Orlistat—type 2 diabetes mellitus	6.76e-05	0.000316	CcSEcCtD
Zolmitriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.76e-05	0.000316	CcSEcCtD
Zolmitriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	6.75e-05	0.000316	CcSEcCtD
Zolmitriptan—Headache—Orlistat—type 2 diabetes mellitus	6.72e-05	0.000314	CcSEcCtD
Zolmitriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.71e-05	0.000314	CcSEcCtD
Zolmitriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	6.69e-05	0.000313	CcSEcCtD
Zolmitriptan—Somnolence—Ramipril—type 2 diabetes mellitus	6.69e-05	0.000313	CcSEcCtD
Zolmitriptan—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.62e-05	0.00031	CcSEcCtD
Zolmitriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	6.6e-05	0.000309	CcSEcCtD
Zolmitriptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	6.54e-05	0.000306	CcSEcCtD
Zolmitriptan—Dizziness—Metformin—type 2 diabetes mellitus	6.53e-05	0.000306	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.5e-05	0.000304	CcSEcCtD
Zolmitriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.47e-05	0.000303	CcSEcCtD
Zolmitriptan—Nausea—Valsartan—type 2 diabetes mellitus	6.44e-05	0.000302	CcSEcCtD
Zolmitriptan—Constipation—Ramipril—type 2 diabetes mellitus	6.43e-05	0.000301	CcSEcCtD
Zolmitriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000299	CcSEcCtD
Zolmitriptan—Nausea—Orlistat—type 2 diabetes mellitus	6.37e-05	0.000298	CcSEcCtD
Zolmitriptan—Asthenia—Losartan—type 2 diabetes mellitus	6.3e-05	0.000295	CcSEcCtD
Zolmitriptan—Vomiting—Metformin—type 2 diabetes mellitus	6.28e-05	0.000294	CcSEcCtD
Zolmitriptan—Rash—Metformin—type 2 diabetes mellitus	6.23e-05	0.000292	CcSEcCtD
Zolmitriptan—Dermatitis—Metformin—type 2 diabetes mellitus	6.22e-05	0.000291	CcSEcCtD
Zolmitriptan—Pruritus—Losartan—type 2 diabetes mellitus	6.21e-05	0.000291	CcSEcCtD
Zolmitriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	6.2e-05	0.00029	CcSEcCtD
Zolmitriptan—Headache—Metformin—type 2 diabetes mellitus	6.19e-05	0.00029	CcSEcCtD
Zolmitriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	6.17e-05	0.000289	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000288	CcSEcCtD
Zolmitriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	6e-05	0.000281	CcSEcCtD
Zolmitriptan—Urticaria—Ramipril—type 2 diabetes mellitus	5.98e-05	0.00028	CcSEcCtD
Zolmitriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000278	CcSEcCtD
Zolmitriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.95e-05	0.000278	CcSEcCtD
Zolmitriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	5.93e-05	0.000278	CcSEcCtD
Zolmitriptan—Rash—Irbesartan—type 2 diabetes mellitus	5.88e-05	0.000275	CcSEcCtD
Zolmitriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000275	CcSEcCtD
Zolmitriptan—Nausea—Metformin—type 2 diabetes mellitus	5.87e-05	0.000275	CcSEcCtD
Zolmitriptan—Headache—Irbesartan—type 2 diabetes mellitus	5.84e-05	0.000273	CcSEcCtD
Zolmitriptan—Dizziness—Losartan—type 2 diabetes mellitus	5.8e-05	0.000272	CcSEcCtD
Zolmitriptan—Vomiting—Losartan—type 2 diabetes mellitus	5.58e-05	0.000261	CcSEcCtD
Zolmitriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000259	CcSEcCtD
Zolmitriptan—Nausea—Irbesartan—type 2 diabetes mellitus	5.54e-05	0.000259	CcSEcCtD
Zolmitriptan—Rash—Losartan—type 2 diabetes mellitus	5.53e-05	0.000259	CcSEcCtD
Zolmitriptan—Dermatitis—Losartan—type 2 diabetes mellitus	5.53e-05	0.000259	CcSEcCtD
Zolmitriptan—Headache—Losartan—type 2 diabetes mellitus	5.5e-05	0.000257	CcSEcCtD
Zolmitriptan—Asthenia—Ramipril—type 2 diabetes mellitus	5.4e-05	0.000253	CcSEcCtD
Zolmitriptan—Pruritus—Ramipril—type 2 diabetes mellitus	5.32e-05	0.000249	CcSEcCtD
Zolmitriptan—Nausea—Losartan—type 2 diabetes mellitus	5.21e-05	0.000244	CcSEcCtD
Zolmitriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000241	CcSEcCtD
Zolmitriptan—Dizziness—Ramipril—type 2 diabetes mellitus	4.98e-05	0.000233	CcSEcCtD
Zolmitriptan—Vomiting—Ramipril—type 2 diabetes mellitus	4.78e-05	0.000224	CcSEcCtD
Zolmitriptan—Rash—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000222	CcSEcCtD
Zolmitriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	4.74e-05	0.000222	CcSEcCtD
Zolmitriptan—Headache—Ramipril—type 2 diabetes mellitus	4.71e-05	0.000221	CcSEcCtD
Zolmitriptan—Nausea—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000209	CcSEcCtD
Zolmitriptan—HTR1B—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.26e-05	0.000143	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.25e-05	0.000143	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ACACA—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD17B3—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—STAR—type 2 diabetes mellitus	1.25e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—LPL—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOB—type 2 diabetes mellitus	1.24e-05	0.000142	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.24e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.23e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.23e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.23e-05	0.000141	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.22e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.22e-05	0.000139	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ADCY5—type 2 diabetes mellitus	1.22e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOB—type 2 diabetes mellitus	1.21e-05	0.000139	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX1—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1R—type 2 diabetes mellitus	1.21e-05	0.000138	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CBS—type 2 diabetes mellitus	1.2e-05	0.000137	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ABCC8—type 2 diabetes mellitus	1.2e-05	0.000137	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EDN1—type 2 diabetes mellitus	1.19e-05	0.000136	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LPL—type 2 diabetes mellitus	1.18e-05	0.000135	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.18e-05	0.000135	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CD36—type 2 diabetes mellitus	1.18e-05	0.000135	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPP2CA—type 2 diabetes mellitus	1.17e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.16e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.16e-05	0.000133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LPL—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.16e-05	0.000132	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC5A2—type 2 diabetes mellitus	1.15e-05	0.000131	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—COX2—type 2 diabetes mellitus	1.15e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.14e-05	0.000131	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.14e-05	0.00013	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ADCY5—type 2 diabetes mellitus	1.13e-05	0.00013	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NCOA6—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	1.13e-05	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GCG—type 2 diabetes mellitus	1.12e-05	0.000129	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.12e-05	0.000129	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTHFR—type 2 diabetes mellitus	1.12e-05	0.000128	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—UCP2—type 2 diabetes mellitus	1.11e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD11B1—type 2 diabetes mellitus	1.11e-05	0.000127	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—UCP3—type 2 diabetes mellitus	1.11e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.11e-05	0.000127	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.11e-05	0.000126	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.1e-05	0.000126	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARA—type 2 diabetes mellitus	1.1e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RELA—type 2 diabetes mellitus	1.09e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.09e-05	0.000125	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.09e-05	0.000124	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	1.08e-05	0.000123	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.07e-05	0.000122	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—C3—type 2 diabetes mellitus	1.07e-05	0.000122	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AGT—type 2 diabetes mellitus	1.06e-05	0.000121	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.05e-05	0.00012	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PCK1—type 2 diabetes mellitus	1.04e-05	0.000119	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—CALM1—type 2 diabetes mellitus	1.04e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	1.04e-05	0.000119	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOE—type 2 diabetes mellitus	1.04e-05	0.000119	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.03e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.03e-05	0.000118	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—APOA1—type 2 diabetes mellitus	1.03e-05	0.000118	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	1.03e-05	0.000118	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.02e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.01e-05	0.000116	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AGT—type 2 diabetes mellitus	1.01e-05	0.000116	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	1e-05	0.000115	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.96e-06	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.95e-06	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.95e-06	0.000114	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.93e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—LEP—type 2 diabetes mellitus	9.92e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOE—type 2 diabetes mellitus	9.92e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	9.91e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.87e-06	0.000113	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.81e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.8e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.79e-06	0.000112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HK1—type 2 diabetes mellitus	9.78e-06	0.000112	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	9.77e-06	0.000112	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.75e-06	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	9.71e-06	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	9.71e-06	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.7e-06	0.000111	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	9.6e-06	0.00011	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	9.57e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.57e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.52e-06	0.000109	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.48e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HSD3B2—type 2 diabetes mellitus	9.45e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCKR—type 2 diabetes mellitus	9.45e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPA—type 2 diabetes mellitus	9.45e-06	0.000108	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—KCNJ11—type 2 diabetes mellitus	9.45e-06	0.000108	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.38e-06	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.35e-06	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.32e-06	0.000107	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.24e-06	0.000106	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—NFKB1—type 2 diabetes mellitus	9.22e-06	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.21e-06	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	9.16e-06	0.000105	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.1e-06	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	9.08e-06	0.000104	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PPARG—type 2 diabetes mellitus	9.07e-06	0.000104	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALDOB—type 2 diabetes mellitus	9.06e-06	0.000104	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—AKT1—type 2 diabetes mellitus	9.04e-06	0.000103	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—INS—type 2 diabetes mellitus	8.89e-06	0.000102	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.85e-06	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	8.83e-06	0.000101	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	8.8e-06	0.000101	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.67e-06	9.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.64e-06	9.88e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	8.62e-06	9.85e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SRC—type 2 diabetes mellitus	8.6e-06	9.82e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	8.52e-06	9.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—INS—type 2 diabetes mellitus	8.47e-06	9.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	8.42e-06	9.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.37e-06	9.57e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.34e-06	9.53e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	8.3e-06	9.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.28e-06	9.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.2e-06	9.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.19e-06	9.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	8.16e-06	9.33e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—EGFR—type 2 diabetes mellitus	8.16e-06	9.32e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—type 2 diabetes mellitus	8.15e-06	9.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.13e-06	9.29e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	8.03e-06	9.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	8.02e-06	9.17e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	7.99e-06	9.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	7.95e-06	9.08e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	7.86e-06	8.98e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	7.8e-06	8.91e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	7.8e-06	8.91e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.78e-06	8.9e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	7.7e-06	8.8e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	7.7e-06	8.8e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.68e-06	8.78e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.62e-06	8.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.58e-06	8.66e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.56e-06	8.64e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	7.55e-06	8.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.55e-06	8.63e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.53e-06	8.61e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	7.51e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	7.51e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	7.51e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	7.51e-06	8.58e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	7.46e-06	8.52e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.43e-06	8.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.43e-06	8.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.43e-06	8.49e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.4e-06	8.46e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.4e-06	8.46e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	7.33e-06	8.37e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.31e-06	8.36e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	7.28e-06	8.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	7.28e-06	8.32e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	7.24e-06	8.28e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	7.13e-06	8.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	7e-06	7.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.98e-06	7.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	6.85e-06	7.83e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.75e-06	7.72e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	6.73e-06	7.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	6.73e-06	7.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	6.73e-06	7.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	6.61e-06	7.55e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.6e-06	7.54e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	6.55e-06	7.48e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.46e-06	7.38e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	6.41e-06	7.32e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.37e-06	7.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	6.32e-06	7.22e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.31e-06	7.21e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.27e-06	7.16e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	6.24e-06	7.13e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.22e-06	7.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	6.18e-06	7.06e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	6.16e-06	7.04e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	6.14e-06	7.01e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.11e-06	6.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.11e-06	6.98e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	6.09e-06	6.96e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.08e-06	6.95e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.96e-06	6.81e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	5.94e-06	6.79e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.91e-06	6.75e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.9e-06	6.74e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.84e-06	6.67e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	5.84e-06	6.67e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	5.84e-06	6.67e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.81e-06	6.64e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—type 2 diabetes mellitus	5.79e-06	6.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.78e-06	6.61e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.78e-06	6.6e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.66e-06	6.47e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.54e-06	6.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.54e-06	6.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	5.5e-06	6.28e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	5.38e-06	6.15e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.35e-06	6.12e-05	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.34e-06	6.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.24e-06	5.99e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.22e-06	5.96e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	5.03e-06	5.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.03e-06	5.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	5.01e-06	5.72e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	4.94e-06	5.65e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.91e-06	5.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.82e-06	5.51e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.81e-06	5.5e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	4.8e-06	5.48e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.75e-06	5.43e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.72e-06	5.39e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.71e-06	5.38e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.68e-06	5.34e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	4.67e-06	5.33e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	4.58e-06	5.23e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	4.48e-06	5.12e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	4.47e-06	5.11e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.45e-06	5.08e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.4e-06	5.03e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	4.35e-06	4.97e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.31e-06	4.93e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	4.3e-06	4.91e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	4.12e-06	4.71e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.1e-06	4.69e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	4.05e-06	4.62e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.99e-06	4.56e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	3.92e-06	4.48e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	3.85e-06	4.4e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	3.84e-06	4.39e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	3.8e-06	4.34e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	3.7e-06	4.23e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.67e-06	4.19e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	3.63e-06	4.14e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.59e-06	4.11e-05	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	3.58e-06	4.1e-05	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.42e-06	3.9e-05	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.35e-06	3.82e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	3.34e-06	3.82e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	3.28e-06	3.75e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	3.01e-06	3.44e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.88e-06	3.29e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	2.88e-06	3.29e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.76e-06	3.16e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	2.63e-06	3.01e-05	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.55e-06	2.91e-05	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	1.32e-06	1.51e-05	CbGpPWpGaD
